Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The clinical and financial burdens of stroke are considerable. Stroke is the leading cause of death and disability in the developed world and incidence is rapidly increasing in the developing world. However, investment in research to combat stroke has been remarkably poor. Studies from the United Kingdom, Europe and the United States have shown a highly consistent picture, with considerably lower levels of funding for stroke research compared with cancer and heart disease. Without better funding for stroke research, it is unlikely that progress in prevention and treatment will offset the projected increases in the burden of stroke. Stroke physicians and public interest groups need to be active advocates in securing increased funding for stroke research.

Original publication




Journal article


Int J Stroke

Publication Date





80 - 84


Biomedical Research, Financing, Government, Global Health, Humans, International Cooperation, Research Support as Topic, Stroke